Molecules (Oct 2020)

<i>p</i>-Cymene Complexes of Ruthenium(II) as Antitumor Agents

  • María Angeles Pujante-Galián,
  • Sergio A. Pérez,
  • Mercedes G. Montalbán,
  • Guzmán Carissimi,
  • Marta G. Fuster,
  • Gloria Víllora,
  • Gabriel García

DOI
https://doi.org/10.3390/molecules25215063
Journal volume & issue
Vol. 25, no. 21
p. 5063

Abstract

Read online

In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η6-p-cymene)RuCl2L] (I-VI), L = 4-cyanopyridine (I), 2-aminophenol (II), 4-aminophenol (III), pyridazine (IV), and [(η6-p-cymene)RuClL2]PF6; L = cyanopyridine (V), L = 2-aminophenol(VI) towards three cell lines was studied. Two of them, HeLa and MCF-7, are human carcinogenic cells from cervical carcinoma and human breast cancer, respectively. A comparison with healthy cells was carried out with BGM cells which are monkey epithelial cells of renal origin. The behavior of complex II exhibits selectivity towards healthy cells, which is a promising feature for use in cancer treatment since it might reduce the side effects of most current therapies.

Keywords